M2.9 PH1 ADC

N/A

Report date: 2025/11/18 09:32:48

Base Information

Drug NameM2.9 PH1 ADC
Drug Alias NameM2.9 PH1 ADCTrop2 PH1 ADC
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionRNA splicing modulatorsAnti-Trop-2
TargetsTumor-associated calcium signal transducer 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPeak Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeak Bio Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A